Roundhill Investments Launches GLP-1 & Weight Loss ETF
Roundhill Investments Launches GLP-1 & Weight Loss ETF
朗德希尔投资推出 GLP-1 和减肥ETF
OZEM provides exposure to the rapidly growing weight loss management market, which is expected to reach $100 billion by 2030.
OZEM为快速增长的减肥管理市场提供了机会，预计到2030年减肥管理市场将达到1000亿美元。
NEW YORK, May 21, 2024 /PRNewswire/ -- Roundhill Investments, an ETF sponsor focused on innovative financial products, is pleased to announce the launch of the Roundhill GLP-1 & Weight Loss ETF (OZEM), which began trading on Nasdaq today. OZEM is the world's first ETF focused exclusively on the rapidly growing sector of GLP-1 receptor agonists and other weight management drugs.
纽约，2024年5月21日 /PRNewswire/ — 专注于创新金融产品的ETF赞助商Roundhill Investments欣然宣布推出朗德希尔 GLP-1 和减肥ETF（OZEM），该ETF于今天在纳斯达克开始交易。OZEM 是世界上第一只专注于快速增长的 GLP-1 受体激动剂和其他体重管理药物领域的ETF。